Advanced Search
Current and Breaking News for Professionals, Consumers and Media

Click here to learn how to advertise on this site and for ad rates.

Heart Health Author: Yale School of Medicine Last Updated: Mar 9, 2010 - 1:09:23 PM



New Method to Grow Arteries Could Lead to “Biological Bypass” for Heart Disease

By Yale School of Medicine
Mar 9, 2010 - 1:06:42 PM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page
(HealthNewsDigest.com) - New Haven, Conn. — A new method of growing arteries could lead to a “biological bypass”—a non-invasive way to treat coronary artery disease—Yale School of Medicine researchers and their colleagues report in the April issue of the Journal of Clinical Investigation.

Coronary arteries can become blocked with plaque, leading to a decrease in the supply of blood and oxygen to the heart. Over time this blockage can lead to debilitating chest pain or heart attack. Severe blockages in multiple major vessels may require coronary artery bypass graft surgery, a major invasive surgery.

“Successfully growing new arteries could provide a biological option for patients facing bypass surgery,” said lead author of the study, Michael Simons, M.D., chief of the Section of Cardiology at Yale School of Medicine.

In the past, researchers used growth factors—proteins that stimulate the growth of cells—in an attempt to grow new arteries, but this method was unsuccessful. Simons and his team studied mice and zebrafish to see if they could simulate arterial formation by switching on and off two signaling pathways: ERK1/2 and PI3K.

“We found that there is cross-talk between the two signaling pathways. One half of the signaling pathway inhibits the other. When we disable the inhibitor mechanism, we are able to grow arteries,” said Simons. “Instead of using growth factors, we stopped the inhibitor mechanism by using a drug that targets a particular enzyme called PI3-kinase inhibitor.”

“Because we’ve located this inhibitory pathway, this opens the possibility of developing a new class of medication to grow new arteries,” Simons added. “The next step is to test this finding in a human clinical trial.”

Other authors on the study included Bin Ren, Yong Den, Arpita Mukhopadhyay, Anthony A. Lanahan, Zhen W. Zhuang, Karen L. Moodie, Mary Jo Mulligan-Kehoe, Tatiana V. Byzova, and Randall T. Peterson

The Journal of Clinical Investigation Vol. 120, No. 4 (April 2010)

Subscribe to our FREE Ezine and be eligible for Health News, discounted products/services and coupons related to your Health. We publish 24/7.
HealthNewsDigest.com
We videotape Press Conferences, produce Satellite MediaTour's, B-rolls, PSA's, - all with distribution: HealthyTelevisionProductionstvmike13@healthnewsdigest.com



Top of Page

HealthNewsDigest.com

Heart Health
Latest Headlines


+ Women of Color Have More Risk Factors for Heart Disease
+ Is Alcohol Really Good for the Heart?
+ Is Heart Disease Or Stroke A Part Of Your Family History?
+ Your Pharmacist Can Be a Great Resource in Your Quest for Heart Health
+ Stents and Surgery For Blocked Neck Arteries are Neck-and-Neck as Lasting Stroke Prevention
+ Leesburg Regional Medical Center Physicians Perform Region's First Aortic Valve Replacement via Catheter
+ Middle-age Risk Factors Drive Greater Risk for Heart Disease
+ Congenital Heart Patients to Benefit From Wireless, Battery-Free Cardiac Implant
+ Matters of the Heart: Women and Heart Disease
+ Sexual Activity is Safe for Most Heart, Stroke Patients



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions